Related content

Phase I clinical trial of lenalidomide in combination with temsirolimus in patients with advanced cancer

By Ganesan Prasanth   Piha-Paul Sarina   Naing Aung   Falchook Gerald   Wheler Jennifer   Janku Filip   Zinner Ralph   Laday Shell   Kies Merrill   Tsimberidou Apostolia  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1505-1513

Springer Publishing Company

Access to resources Recommend Favorite

Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non–small cell lung cancer

By Okamoto Isamu   Miyazaki Masaki   Morinaga Ryotaro   Kaneda Hiroyasu   Ueda Shinya   Hasegawa Yoshikazu   Satoh Taroh   Kawada Akira   Fukuoka Masahiro   Fukino Koichi   Tanigawa Takahiko   Nakagawa Kazuhiko  

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 844-853

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of sorafenib in combination with ifosfamide in patients with advanced sarcoma: a Spanish group for research on sarcomas (GEIS) study

By Martín-Liberal J.   López-Pousa A.   Broto J.   Cubedo R.   Gallego O.   Brendel E.   Tirado O.   Muro X.  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 287-294

Springer Publishing Company

Access to resources Recommend Favorite

Open-label phase I trial of vandetanib in combination with mFOLFOX6 in patients with advanced colorectal cancer

By Michael Michael   Gibbs Peter   Smith Robert   Godwood Alex   Oliver Stuart   Tebbutt Niall  

Investigational New Drugs, Vol. 27, Iss. 3, 2009-06 ,pp. : 253-261

Springer Publishing Company

Access to resources Recommend Favorite

Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma

By Lee Su  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1540-1547

Springer Publishing Company

Access to resources Recommend Favorite